jnccn.org/abstract/journals/jnccn/16/4/article-p359.xml
Preview meta tags from the jnccn.org website.
Linked Hostnames
16- 163 links tojnccn.org
- 128 links toscholar.google.com
- 87 links topubmed.ncbi.nlm.nih.gov
- 38 links towww.ncbi.nlm.nih.gov
- 2 links towww.nccn.org
- 1 link toclinicaltrials.gov
- 1 link todoi.org
- 1 link toeducation.nccn.org
Thumbnail
Search Engine Appearance
NCCN Guidelines Insights: Colon Cancer, Version 2.2018
The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of BRAF V600E mutation–positive metastatic colorectal cancer with regimens containing vemurafenib.
Bing
NCCN Guidelines Insights: Colon Cancer, Version 2.2018
The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of BRAF V600E mutation–positive metastatic colorectal cancer with regimens containing vemurafenib.
DuckDuckGo
NCCN Guidelines Insights: Colon Cancer, Version 2.2018
The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of BRAF V600E mutation–positive metastatic colorectal cancer with regimens containing vemurafenib.
General Meta Tags
95- titleNCCN Guidelines Insights: Colon Cancer, Version 2.2018 in: Journal of the National Comprehensive Cancer Network Volume 16 Issue 4 (2018)
- Content-Typetext/html; charset=utf-8
- descriptionThe NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of BRAF V600E mutation–positive metastatic colorectal cancer with regimens containing vemurafenib.
- article:authorAl B. Benson III
- article:authorAlan P. Venook
Open Graph Meta Tags
7- og:urlhttps://jnccn.org/view/journals/jnccn/16/4/article-p359.xml
- og:site_nameJNCCN
- og:typearticle
- og:titleNCCN Guidelines Insights: Colon Cancer, Version 2.2018
- og:descriptionThe NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of BRAF V600E mutation–positive metastatic colorectal cancer with regimens containing vemurafenib.
Twitter Meta Tags
4- twitter:cardsummary_large_image
- twitter:site@jnccn
- twitter:titleNCCN Guidelines Insights: Colon Cancer, Version 2.2018
- twitter:descriptionThe NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of BRAF V600E mutation–positive metastatic colorectal cancer with regimens containing vemurafenib.
Link Tags
16- alternate/newsrss
- canonicalhttps://jnccn.org/view/journals/jnccn/16/4/article-p359.xml
- dns-prefetch//ajax.googleapis.com
- preconnect//ajax.googleapis.com
- preconnect//ajax.googleapis.com
Emails
2- [email protected]
- ?subject=Link%20to%20NCCN%20Guidelines%20Insights%3A%20Colon%20Cancer%2C%20Version%202.2018&body=https%3A%2F%2Fjnccn.org%2Fview%2Fjournals%2Fjnccn%2F16%2F4%2Farticle-p359.xml
Links
429- http://ClinicalTrials.gov
- http://NCCN.org
- http://scholar.google.com/scholar_lookup?title=A+metastatic+colon+adenocarcinoma+harboring+BRAF+V600E+has+a+durable+major+response+to+dabrafenib%2Ftrametinib+and+chemotherapy&author=CB+C+SM+Williams+McMahon+Ali&publication_year=2015&journal=Onco+Targets+Ther&volume=8&pages=3561-3564
- http://scholar.google.com/scholar_lookup?title=Achievements+and+challenges+of+molecular+targeted+therapy+in+melanoma&author=R+P+S+R+Sullivan+LoRusso+Boerner+Dummer&publication_year=2015&journal=Am+Soc+Clin+Oncol+Educ+Book&pages=177-186
- http://scholar.google.com/scholar_lookup?title=Adjuvant+chemotherapy+is+associated+with+improved+survival+in+patients+with+stage+II+colon+cancer&author=L+G+M+Casadaban+Rauscher+Aklilu&publication_year=2016&journal=Cancer&volume=122&pages=3277-3287